Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation.

导出 OA

翻译打印收藏纠错

第一作者： Ki Won,Hwang

第一单位： Division of Cardiology, Department of Internal Medicine, School of Medicine, Pusan National University, Pusan National University Yangsan Hospital, 20, Geumo-ro, Mulgeum-eup, Yangsan, Gyeongnam, 626-770, South Korea. korea.hwang@gmail.com.

作者： Ki Won,Hwang ^[1] ; Jin Hee,Choi ^[2] ; Soo Yong,Lee ^[2] ; Sang Hyun,Lee ^[2] ; Min Ku,Chon ^[2] ; Jungkuk,Lee ^[3] ; Hasung,Kim ^[3] ; Yong-Giun,Kim ^[4] ; Hyung Oh,Choi ^[5] ; Jeong Su,Kim ^[2] ; Yong-Hyun,Park ^[2] ; June Hong,Kim ^[2] ; Kook Jin,Chun ^[2] ; Gi-Byoung,Nam ^[6] ; Kee-Joon,Choi ^[6]

作者单位： Division of Cardiology, Department of Internal Medicine, School of Medicine, Pusan National University, Pusan National University Yangsan Hospital, 20, Geumo-ro, Mulgeum-eup, Yangsan, Gyeongnam, 626-770, South Korea. korea.hwang@gmail.com. ^[1] Division of Cardiology, Department of Internal Medicine, School of Medicine, Pusan National University, Pusan National University Yangsan Hospital, 20, Geumo-ro, Mulgeum-eup, Yangsan, Gyeongnam, 626-770, South Korea. ^[2] Data Science Team, Hanmi Pharm. Co., Ltd, Seoul, Republic of Korea. ^[3] Division of Cardiology, Department of Internal Medicine, University of Ulsan College of Medicine, Ulsan, Republic of Korea. ^[4] Division of Cardiology, Department of Internal Medicine, Soonchunhyang University Hospital, Bucheon, Gyeonggi-do, Republic of Korea. ^[5] Heart Institute, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea. ^[6]

关键词 Anticoagulation Atrial fibrillation Drug-drug interactions Rifampin Tuberculosis